Eva Natukunda

5PUBLICATIONS
18CO-AUTHORS
Infant and child healthTranslation and interpretation studiesNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 24, 2026
Body Composition Changes in Children Living With HIV Initiated on Dolutegravir or Protease Inhibitors in the CHAPAS-4 Trial.

Eva Natukunda, Alex J Szubert, Mutsa Bwakura-Dangarembizi

|Feb 17, 2026
Longitudinal changes in bone mineral density among children living with HIV over 96 weeks following switch to second-line antiretroviral therapy in Uganda.

Eva Natukunda, Erisa Mwaka, Alexander J Szubert

|Jul 09, 2025
Longitudinal Evaluation of Bone Safety in Children and Adolescents With HIV-1 Starting Tenofovir Alafenamide-Containing Antiretroviral Therapy.

Eva Natukunda, Aditya H Gaur, Jaime Gerardo Deville

|Jan 31, 2025
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kg.

Eva Natukunda, Aditya H Gaur, Pope Kosalaraksa

|Jul 20, 2023
Bone mineral density among children living with HIV failing first-line anti-retroviral therapy in Uganda: A sub-study of the CHAPAS-4 trial.

Eva Natukunda, Alex Szubert, Caroline Otike

Pageof 1

Frequent Collaborators

2 joint publications

Katja Doerholt

2 joint publications

Spencer Byaruhanga

2 joint publications

Victor Musiime

2 joint publications

Ann Sarah Walker